SCHEMBL10158692

SCHEMBL10158692

BCc1nc2ccccc2c(I)c1[C@H](OC(C)(C)C)C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EDNRA P25101 2/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ELANE P08246 6/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GBA1 P04062 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ GLA P06280 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ TACR3 P29371 2/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10158707 0.89 EDNRA (0.36) EDNRAMEN1KMT2ANPC1GAA
SCHEMBL10158709 0.86 RXFP1 (0.40) EDNRAMEN1KMT2ANPC1GAA
SCHEMBL10157239 0.84 MEN1 (0.45) EDNRAMEN1KMT2ANPC1GAA
SCHEMBL15132897 0.77 KDM4E (0.43) EDNRAMEN1KMT2ANPC1GAA
SCHEMBL10157235 0.76 MEN1 (0.43) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL12992704 0.75 MEN1 (0.47) EDNRAMEN1KMT2ANPC1GAA
SCHEMBL15132898 0.74 SMN1; SMN2 (0.41) MEN1KMT2ANPC1GAARAB9A
SCHEMBL10157230 0.73 CYP3A4 (0.48) MEN1KMT2ANPC1GAARAB9A
SCHEMBL16258491 0.73 CYP3A4 (0.48) MEN1KMT2ANPC1GAARAB9A
SCHEMBL12992709 0.71 PSIP1 (0.45) MEN1KMT2AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220076-B1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INT (DE) 2012-01-18 — — EP disclosed
Send feedback